Cranford Pharmaceuticals was created to hold the rights to Inderal LA, a prescription beta blocker.
Inderal LA is the long-acting drug propranolol LA, primarily prescribed for hypertension and migraines. Cranford also created Inderal XL, a patented product which improved the existing drug with new technology. Cranford sold Inderal LA and Inderal XL to ANI Pharmaceuticals.